Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy.

MLA

del Amo-Maestro, Laura, et al. “Molecular and in Vivo Studies of a Glutamate-Class Prolyl-Endopeptidase for Coeliac Disease Therapy.” Nature Communications, vol. 13, no. 1, Aug. 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41467-022-32215-1.

APA

del Amo-Maestro, L., Mendes, S. R., Rodríguez-Banqueri, A., Garzon-Flores, L., Girbal, M., Rodríguez-Lagunas, M. J., Guevara, T., Franch, À., Pérez-Cano, F. J., Eckhard, U., & Gomis-Rüth, F. X. (2022). Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy. Nature Communications, 13(1), 1–16. https://doi.org/10.1038/s41467-022-32215-1

Chicago

del Amo-Maestro, Laura, Soraia R. Mendes, Arturo Rodríguez-Banqueri, Laura Garzon-Flores, Marina Girbal, María José Rodríguez-Lagunas, Tibisay Guevara, et al. 2022. “Molecular and in Vivo Studies of a Glutamate-Class Prolyl-Endopeptidase for Coeliac Disease Therapy.” Nature Communications 13 (1): 1–16. doi:10.1038/s41467-022-32215-1.